COMMUNIQUÉS West-GlobeNewswire

-
TLC Submits IND to US FDA Application for TLC178, Liposomal Vinorelbine Candidate for Pediatric Rhabdomyosarcoma
03/06/2018 - 07:00 -
Celldex Presents Promising Data from Phase 1/2 Study of Varlilumab and Opdivo® at 2018 ASCO Annual Meeting
02/06/2018 - 22:12 -
Updated Data from Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1m Relapsed or Refractory AML Continue to Show Durable Responses as a Single Agent
02/06/2018 - 22:05 -
New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna® remain in remission almost three years after stopping therapy
02/06/2018 - 22:01 -
Jounce Therapeutics Presents Preliminary Efficacy Data from Ongoing Phase 1/2 ICONIC Trial of JTX-2011 in Patients with Advanced Cancers
02/06/2018 - 22:00 -
Loxo Oncology Announces Positive Interim Clinical Data from LOXO-292 Dose Escalation Trial in RET-Altered Cancers Presented at the American Society of Clinical Oncology Annual Meeting
02/06/2018 - 15:00 -
G1 Therapeutics Presents Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
02/06/2018 - 15:00 -
Updated Myxoid/Round Cell Liposarcoma Data with NY-ESO, Presented at ASCO Annual Meeting, Further Supports Promising Benefit: Risk Profile
02/06/2018 - 14:00 -
National Research Corporation Declares Quarterly Dividend
01/06/2018 - 23:33 -
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/06/2018 - 23:13 -
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/06/2018 - 22:30 -
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/06/2018 - 22:24 -
FDA Classifies HeartWare(TM) HVAD(TM) Systems Unexpected Power Source Switching as Class I Recall
01/06/2018 - 22:23 -
Reata Selected to Present Early-Stage Programs at the BIO International Convention
01/06/2018 - 22:15 -
Agios Presents Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma and Other Solid Tumors
01/06/2018 - 22:15 -
OmniSeq and LabCorp Launch OmniSeq Advance℠ Assay
01/06/2018 - 22:11 -
Xenon Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
01/06/2018 - 22:01 -
ArmadaCare Sponsors Live Webinar on Creating a Talent Winning Organization with World-Renowned Business Advisor and Speaker, Ram Charan
01/06/2018 - 20:21 -
BioSig Technologies to Present at the 8th Annual LD Micro Invitational
01/06/2018 - 18:55
Pages